1![COMMENTARY Therapeutic Targeting of B Cells and T Cells in Autoimmune Diabetes Is It a Solution? Lucienne Chatenoud COMMENTARY Therapeutic Targeting of B Cells and T Cells in Autoimmune Diabetes Is It a Solution? Lucienne Chatenoud](https://www.pdfsearch.io/img/f1a4c61e3b54469f6de78d458d09426f.jpg) | Add to Reading ListSource URL: diabetes.diabetesjournals.orgLanguage: English |
---|
2![A Single Course of Anti-CD3 Monoclonal Antibody hOKT3␥1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years after Onset of Type 1 Diabetes Kevan C. Herold,1 Stephen E. Gi A Single Course of Anti-CD3 Monoclonal Antibody hOKT3␥1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years after Onset of Type 1 Diabetes Kevan C. Herold,1 Stephen E. Gi](https://www.pdfsearch.io/img/7e768f617d4315c3241f1722b10c60da.jpg) | Add to Reading ListSource URL: diabetes.diabetesjournals.orgLanguage: English - Date: 2005-05-10 10:04:46
|
---|
3![ZENAPAX (daclizumab) STERILE CONCENTRATE FOR INJECTION Rx only WARNING Only physicians experienced in immunosuppressive therapy and management of ZENAPAX (daclizumab) STERILE CONCENTRATE FOR INJECTION Rx only WARNING Only physicians experienced in immunosuppressive therapy and management of](https://www.pdfsearch.io/img/e8a03e361169233c49df106d7a08584c.jpg) | Add to Reading ListSource URL: www.gene.comLanguage: English - Date: 2014-03-31 07:24:10
|
---|
4![Editorial For reprint orders, please contact [removed] EBV infection and anti-CD3 treatment for Type 1 diabetes: bad cop, good cop? Expert Rev. Clin. Immunol. 9(2), 95–[removed]) Editorial For reprint orders, please contact [removed] EBV infection and anti-CD3 treatment for Type 1 diabetes: bad cop, good cop? Expert Rev. Clin. Immunol. 9(2), 95–[removed])](https://www.pdfsearch.io/img/251d9a71e7bfd7d0580e28d360b509ef.jpg) | Add to Reading ListSource URL: www.faustmanlab.orgLanguage: English - Date: 2013-12-11 22:21:47
|
---|